NeuroFlex Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Latest Deal Amount
  • $79.2K

  • Investors
  • 9

NeuroFlex General Information

Description

Developer of an eye-tracking technology designed for the evaluation of brain function. The company's system uses virtual reality to conduct eye-tracking tests of oculomotor, cognitive, and vestibular reaction times producing longitudinal records, enabling clinicians to make informed diagnoses.

Contact Information

Formerly Known As
Saccade Analytics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 240 Richmond Street West
  • Toronto, Ontario M5V 1V6
  • Canada
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 240 Richmond Street West
  • Toronto, Ontario M5V 1V6
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroFlex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private $79.2K Completed Generating Revenue
7. Early Stage VC 12-Jun-2019 Completed Generating Revenue
6. Grant 28-May-2019 Completed Startup
5. Grant 07-Jun-2018 Completed Startup
4. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
3. Accelerator/Incubator 10-May-2017 Completed Startup
2. Accelerator/Incubator 01-Jan-2017 Completed Startup
1. Accelerator/Incubator Completed Startup
To view NeuroFlex’s complete valuation and funding history, request access »

NeuroFlex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroFlex Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anges Québec Angel Group Minority
Invest Nova Scotia Venture Capital Minority
Powerhouse Ventures (Australia) Venture Capital Minority
L'Oréal Canada Corporation
McGill University University
You’re viewing 5 of 9 investors. Get the full list »

NeuroFlex FAQs

  • When was NeuroFlex founded?

    NeuroFlex was founded in 2016.

  • Where is NeuroFlex headquartered?

    NeuroFlex is headquartered in Toronto, Canada.

  • What is the size of NeuroFlex?

    NeuroFlex has 24 total employees.

  • What industry is NeuroFlex in?

    NeuroFlex’s primary industry is Diagnostic Equipment.

  • Is NeuroFlex a private or public company?

    NeuroFlex is a Private company.

  • What is NeuroFlex’s current revenue?

    The current revenue for NeuroFlex is .

  • Who are NeuroFlex’s investors?

    Anges Québec, Invest Nova Scotia, Powerhouse Ventures (Australia), L'Oréal Canada, and McGill University are 5 of 9 investors who have invested in NeuroFlex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process